Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 11 studies | 43% ± 19% | |
pericyte | 6 studies | 36% ± 11% | |
smooth muscle cell | 5 studies | 30% ± 16% |
Insufficient scRNA-seq data for expression of INMT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 97% | 3880.89 | 237 / 245 | 98% | 23.59 | 491 / 502 |
thymus | 97% | 2843.80 | 634 / 653 | 89% | 68.45 | 539 / 605 |
lung | 100% | 25203.84 | 578 / 578 | 75% | 15.51 | 861 / 1155 |
adrenal gland | 100% | 6122.62 | 258 / 258 | 63% | 9.53 | 145 / 230 |
kidney | 83% | 2046.98 | 74 / 89 | 69% | 10.27 | 618 / 901 |
pancreas | 42% | 530.18 | 139 / 328 | 91% | 21.45 | 162 / 178 |
liver | 69% | 1437.17 | 156 / 226 | 53% | 6.82 | 215 / 406 |
bladder | 67% | 1234.10 | 14 / 21 | 50% | 4.27 | 250 / 504 |
breast | 68% | 1153.54 | 314 / 459 | 42% | 3.34 | 470 / 1118 |
esophagus | 74% | 3602.46 | 1064 / 1445 | 35% | 2.62 | 64 / 183 |
intestine | 51% | 856.46 | 494 / 966 | 57% | 4.90 | 299 / 527 |
stomach | 42% | 1200.59 | 149 / 359 | 59% | 5.44 | 170 / 286 |
blood vessel | 100% | 6197.17 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 4317.79 | 832 / 861 | 0% | 0 | 0 / 0 |
adipose | 86% | 4260.55 | 1032 / 1204 | 0% | 0 | 0 / 0 |
uterus | 68% | 1703.41 | 115 / 170 | 18% | 1.23 | 81 / 459 |
ovary | 61% | 1928.24 | 110 / 180 | 17% | 1.13 | 74 / 430 |
spleen | 69% | 1456.93 | 167 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 3.12 | 14 / 29 |
skin | 17% | 195.66 | 302 / 1809 | 26% | 2.18 | 123 / 472 |
tonsil | 0% | 0 | 0 / 0 | 38% | 1.94 | 17 / 45 |
brain | 0% | 3.19 | 8 / 2642 | 22% | 2.76 | 155 / 705 |
muscle | 4% | 41.89 | 33 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.15 | 3 / 80 |
peripheral blood | 1% | 10.63 | 7 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009636 | Biological process | response to toxic substance |
GO_0032259 | Biological process | methylation |
GO_0009308 | Biological process | amine metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0008170 | Molecular function | N-methyltransferase activity |
GO_0030748 | Molecular function | amine N-methyltransferase activity |
GO_0102707 | Molecular function | S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity |
GO_0004790 | Molecular function | thioether S-methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | INMT |
Protein name | HCG2044801 (Indolethylamine N-methyltransferase) INMT protein Indolethylamine N-methyltransferase (Indolamine N-methyltransferase) (EC 2.1.1.49) (EC 2.1.1.96) (Aromatic alkylamine N-methyltransferase) (Amine N-methyltransferase) (Arylamine N-methyltransferase) (Thioether S-methyltransferase) (TEMT) |
Synonyms | hCG_2044801 tcag7.895 |
Description | FUNCTION: Functions as a thioether S-methyltransferase and is active with a variety of thioethers and the corresponding selenium and tellurium compounds, including 3-methylthiopropionaldehyde, dimethyl selenide, dimethyl telluride, 2-methylthioethylamine, 2-methylthioethanol, methyl-n-propyl sulfide and diethyl sulfide. Plays an important role in the detoxification of selenium compounds (By similarity). Catalyzes the N-methylation of tryptamine and structurally related compounds. . |
Accessions | Q3MIB5 O95050 ENST00000013222.5 [O95050-1] ENST00000409539.1 [O95050-2] A0A090N7V3 |